Post-earnings recap
Reported
Mon, Oct 31, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Zimmer Biomet's earnings report showed a slight EPS beat, but the stock dropped nearly 14%. This decline may reflect investor concerns about broader market challenges and the lack of guidance from management, indicating uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.79 | N/A | +0.06% |
Management expressed concerns about market conditions affecting growth. They reiterated their commitment to improving operational efficiency.
Management highlighted ongoing challenges in the market.
They emphasized a focus on operational efficiency moving forward.